Australian study finds enablers and barriers to COVID-19 vaccine uptake

People’s trust in the government’s approval of a safe and effective vaccine against COVID-19 is the biggest driver of vaccine uptake, an Australian study has found.

Second on the list of motivations identified in the study is the perceived effectiveness of the vaccine to protect others in the community.

The next two most common drivers of vaccine hesitancy were found to be “free-riding”, where individuals believe they can benefit from others taking up the vaccine without being immunized themselves, and conspiracy beliefs about vaccination, capturing the attitudes of “anti-vaxxers”.

The study, conducted by researchers from the Centre for Business Intelligence & Data Analytics at the University of Technology Sydney (UTS), sampled more than 4300 respondents in Australia, New Zealand, the United States, Canada and the United Kingdom, and found 11 factors were enablers or barriers to COVID-19 vaccination.

“This study offers strong insights for improving vaccination coverage, with the challenge of implementing one of the most important vaccination programs in human history,” said Associate Professor Paul Burke, Deputy Director, Centre for Business Intelligence & Data Analytics at UTS Business School.

“While the development of effective vaccine offerings is essential, unless people are going to be vaccinated such programs will not be successful. This study tells us the who and the why to encourage more significant uptake.”

Overall, 66 per cent of respondents agreed they would receive COVID-19 vaccination. Australians had the highest rates of intention (73 per cent), followed by Canada (66 per cent), United Kingdom (64 per cent), New Zealand (62 per cent), and the United States (55 per cent).

At the bottom of the list of vaccination drivers were individuals’ concerns about the severity of COVID-19 if caught and how susceptible they were to becoming infected, although both were significant in explaining vaccine hesitancy.

Many factors drive vaccine hesitancy. Using the health-beliefs model as a starting point, we examined a number of factors relating to the perceived threat of the disease balanced against the benefits and risks of vaccination. What was interesting is that we also accounted for how people judged these risks for themselves, but also others in their community.”

Associate Professor Paul Burke, Deputy Director, Centre for Business Intelligence & Data Analytics at UTS Business School

The model controlled for individual differences such as age, income and gender, as well as the general healthiness of the individual.

Individuals found to have lower rates of vaccine uptake intentions were more likely to be younger or unemployed, but not looking for work. Higher rates of COVID-19 vaccine uptake were identified among older individuals, unemployed individuals looking for work, and those who had previously been vaccinated against influenza. People who held more altruistic and collectivist beliefs were also significantly more likely to be vaccinated.

Drivers of COVID-19 vaccination uptake intentions (largest to smallest)

  1. Trust in government approval of safe & effective COVID-19 vaccine (+)
  2. Perceived effectiveness of COVID-19 vaccination for others (+)
  3. Perceived ability to free-ride (-)
  4. Conspiracy beliefs about vaccination (-)
  5. Perceived side-effects of COVID-19 vaccine (+)
  6. Perceived effectiveness of COVID-19 vaccination for the individual (+)
  7. Perceived COVID-19 vaccine availability (+)
  8. Perceived disease severity for others (+)
  9. Perceived susceptibility to COVID-19 for others (+)
  10. Perceived disease severity for the individual (+)
  11. Perceived susceptibility to COVID-19 for the individual (+)

The study, Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions, is published in the journal Vaccine.

Source:
Journal reference:

Burke, P.F., et al. (2021) Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions. Vaccine. doi.org/10.1016/j.vaccine.2021.07.056.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
COVID-19 booster for immunosuppressed patients with inflammatory bowel disease